GIB Flashcards
Overt GI bleed manifested as ___
hematemesis or “coffee grounds”
melena
hematochezia
Occult GI bleed manifested as ___
symptoms of blood loss or anemia such as lightheadedness, syncope, angina, or dyspnea
Occult GI blood tests
Iron deficiency anemia
fecal occult blood test
most common gastrointestinal condition leading to hospitalization
GIB
The most common cause of upper GIB (UGIB), accounting for ~50% of UGIB hospitalizations.
Peptic ulcer
High-dose, constantinfusion IV proton pump inhibitor (PPI) (_____), designed to sustain intragastric pH ____ and enhance clot stability, decreases further bleeding and mortality in patients with high-risk ulcers (active bleeding, nonbleeding visible vessel, adherent clot) when given after endoscopic therapy.
80-mg bolus and 8-mg/h infusion
> 6
High-dose intermittent PPIs are noninferior to constant-infusion PPI therapy T/F
T
Prevention of recurrent bleeding focuses on the three main factors in ulcer pathogenesis, _____
Helicobacter pylori, nonsteroidal anti-inflammatory drugs (NSAIDs), and acid.
If NSAIDs must be given, a _______ is recommended, based on results of a randomized trial.
cyclooxygenase (COX)-2 selective NSAID plus a PPI
Patients with established cardiovascular disease who develop bleeding ulcers while taking low-dose aspirin for secondary prevention should restart aspirin as soon as possible after their bleeding episode (_____days).
1–7
Aspirin management:
> Restart low-dose aspirin (for primary/secondary? cardiovascular prevention) 1–7 days after bleeding episode.
*Randomized trial: Lower 8-week mortality (1% vs. 13%; hazard ratio, 0.2; 95% CI, 0.1–0.6).
> Discontinue aspirin in most cases of UGIB for primary/secondary? cardiovascular prevention
continue for secondary
discontinue for primary
When should low-dose aspirin for secondary cardiovascular prevention be restarted in patients with bleeding ulcers?
A. Immediately after diagnosis
B. Within 1–7 days
C. After 1 month
D. Never
B
In patients taking NSAIDs, what is the recommended management if NSAIDs must be continued after a bleeding ulcer?
A. Discontinue NSAIDs permanently
B. Use COX-2 selective NSAIDs plus PPI
C. Use low-dose aspirin only
D. Use acetaminophen instead of NSAIDs
B
The classic history of mallory Weiss tears is ____preceding hematemesis, especially in an alcoholic patient.
vomiting, retching, or coughing
Bleeding from these tears, which are usually on the ____ side of the gastroesophageal junction
gastric
Bleeding from mallory weiss tears stops spontaneously 80-90%
T
Esophageal varices are treated with endoscopic ligation and an IV vasoactive medication (octreotide, somatostatin, vapreotide, terlipressin) for____ days.
2–5
_____is recommended in patients who have persistent or recurrent bleeding despite endoscopic and medical therapy.
Transjugular intrahepatic portosystemic shunt (TIPS)
TIPS also should be considered in the first ___ days of hospitalization for acute variceal bleeding in patients with advanced liver disease (Child-Pugh class B, Child-Pugh class C with score ____)
1–2
10–13
Bleeding gastric varices are treated with endoscopic injection of _____, if available; if not, TIPS is performed.
tissue adhesive (e.g., n-butyl cyanoacrylate)
What is the recommended long-term management to prevent recurrent esophageal variceal bleeding?
A. Endoscopic ligation only
B. Nonselective beta blockers only
C. Nonselective beta blockers plus endoscopic ligation
D. Surgical ligation
C
“Over the long term, treatment with nonselective beta blockers plus endoscopic ligation is recommended because the combination is more effective than either alone in reduction of recurrent esophageal variceal bleeding.”
What is the most common clinical history preceding Mallory-Weiss tears?
A. Persistent diarrhea
B. Vomiting, retching, or coughing
C. Abdominal pain radiating to the back
D. Jaundice and fatigue
B
What percentage of Mallory-Weiss tear cases resolve bleeding spontaneously?
A. ~10–20%
B. ~50–60%
C. ~80–90%
D. ~95–100%
C
What is the first-line intervention for actively bleeding Mallory-Weiss tears?
A. Transfusion of blood products
B. Endoscopic therapy
C. IV proton pump inhibitors
D. Surgical repair
B